GREAT WEST LIFE ASSURANCE CO /CAN/ - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
GREAT WEST LIFE ASSURANCE CO /CAN/ ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$274
-62.7%
63,502
-42.9%
0.00%
-50.0%
Q2 2023$735
+0.5%
111,203
+3.3%
0.00%0.0%
Q1 2023$731
-9.1%
107,695
-0.8%
0.00%0.0%
Q4 2022$804
-99.9%
108,572
+72.7%
0.00%0.0%
Q3 2022$621,000
+2.1%
62,873
+12.8%
0.00%0.0%
Q2 2022$608,000
+8.4%
55,717
+15.2%
0.00%
+100.0%
Q1 2022$561,000
-26.0%
48,3680.0%0.00%
-50.0%
Q4 2021$758,000
-9.4%
48,368
-0.1%
0.00%0.0%
Q3 2021$837,000
-19.6%
48,4000.0%0.00%0.0%
Q2 2021$1,041,000
+49.8%
48,400
+4.5%
0.00%0.0%
Q1 2021$695,000
-2.7%
46,313
-14.8%
0.00%
+100.0%
Q4 2020$714,000
+23.7%
54,347
-9.2%
0.00%0.0%
Q3 2020$577,000
-24.5%
59,855
-10.3%
0.00%
-50.0%
Q2 2020$764,000
+6.0%
66,716
-4.5%
0.00%0.0%
Q1 2020$721,000
-33.9%
69,864
+4.2%
0.00%0.0%
Q4 2019$1,091,000
+10.6%
67,025
-4.2%
0.00%0.0%
Q2 2019$986,000
-23.4%
69,9880.0%0.00%
-33.3%
Q1 2019$1,287,000
-23.8%
69,9880.0%0.00%
-40.0%
Q4 2018$1,688,000
+1064.1%
69,988
+1008.8%
0.01%
Q3 2018$145,000
+20.8%
6,3120.0%0.00%
Q2 2018$120,000
-23.6%
6,312
-32.2%
0.00%
Q1 2018$157,000
+11.3%
9,3040.0%0.00%
Q4 2017$141,000
+193.8%
9,304
+244.6%
0.00%
Q3 2017$48,000
+9.1%
2,7000.0%0.00%
Q2 2017$44,000
+15.8%
2,7000.0%0.00%
Q1 2017$38,000
-11.6%
2,7000.0%0.00%
Q4 2016$43,000
-82.8%
2,700
-82.0%
0.00%
Q3 2016$250,000
+197.6%
15,000
+100.0%
0.00%
Q2 2016$84,000
+33.3%
7,5000.0%0.00%
Q1 2016$63,000
-10.0%
7,5000.0%0.00%
Q4 2015$70,000
-17.6%
7,5000.0%0.00%
Q3 2015$85,000
-10.5%
7,5000.0%0.00%
Q2 2015$95,000
+37.7%
7,5000.0%0.00%
Q1 2015$69,000
-35.5%
7,5000.0%0.00%
Q4 2014$107,000
+37.2%
7,5000.0%0.00%
Q3 2014$78,000
-35.5%
7,5000.0%0.00%
Q2 2014$121,0007,5000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders